We serve Chemical Name:3-methyl-2-phenylpentanoic acid CAS:7782-37-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-methyl-2-phenylpentanoic acid
CAS.NO:7782-37-8
Synonyms:erythro-2-phenyl-3-methylpentanoic acid;3-Methyl-2-phenylvaleric acid,mixture of erythro and threo;MFCD00004254;3-Methyl-2-phenyl-valeriansaeure;3-methyl-2-phenyl valeric acid;3-methyl-2-phenyl-pentanoic acid
Molecular Formula:C12H16O2
Molecular Weight:192.25400
HS Code:2916399090
Physical and Chemical Properties:
Melting point:50-52ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:37.30000
Exact Mass:192.11500
LogP:2.90090
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like erythro-2-phenyl-3-methylpentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-methyl-2-phenyl-pentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Methyl-2-phenyl-valeriansaeure Use and application,MFCD00004254 technical grade,usp/ep/jp grade.
Related News: The additional GMP labs will be able to develop and manufacture highly potent API (HPAPI) under GMP standards. The expanded labs and manufacturing facilities are expected to come online between 1Q22 and 3Q22. 3-bromo-2-methylpyridin-4-amine manufacturers The additional GMP labs will be able to develop and manufacture highly potent API (HPAPI) under GMP standards. The expanded labs and manufacturing facilities are expected to come online between 1Q22 and 3Q22. (2E,5E)-2,5-bis[[4-(dimethylamino)phenyl]methylidene]cyclopentan-1-one suppliers In his new role, Grégoire will ensure alignment between NOVA’s business strategy, operations and growth objectives, as well as leading the Modelling and Simulation (M&S) team as NOVA embarks on its next phase of expansion. 4-methoxy-L-tryptophan vendor & factory The European Medicines Agency on Friday rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant (istradefylline), which the US FDA approved in 2019 under the brand name Nourianz.,Building on this progress, recombinant technologies have been key to optimizing the performance of biocatalytic reagents, for example by facilitating a reduction in the amount of enzyme needed to drive a reaction while at the same time increasing the yield.
